Home > Insider Trading > Filing (0001209191-19-054167)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1695580	Kenneth Krogulski	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-09-20	65	$5.33	161,422	No	4	P	Direct
Common Stock	Acquisiton	2019-09-23	65	$5.35	164,287	No	4	P	Direct
Common Stock	Acquisiton	2019-09-24	65	$5.39	164,352	No	4	P	Direct
Common Stock	Acquisiton	2019-09-25	65	$5.38	164,417	No	4	P	Direct
Common Stock	Acquisiton	2019-09-26	65	$5.76	164,482	No	4	P	Direct
Common Stock	Acquisiton	2019-09-27	65	$5.76	164,547	No	4	P	Direct
Common Stock	Acquisiton	2019-09-30	65	$5.89	164,612	No	4	P	Direct
Common Stock	Acquisiton	2019-10-01	65	$5.89	164,677	No	4	P	Direct
Common Stock	Acquisiton	2019-10-02	65	$5.77	164,742	No	4	P	Direct
Common Stock	Acquisiton	2019-10-04	65	$5.76	164,807	No	4	P	Direct
Common Stock	Acquisiton	2019-10-07	65	$5.74	164,872	No	4	P	Direct
Common Stock	Acquisiton	2019-10-08	65	$5.81	164,937	No	4	P	Direct
Common Stock	Acquisiton	2019-10-09	65	$5.78	165,002	No	4	P	Direct
Common Stock	Acquisiton	2019-10-10	65	$5.86	165,067	No	4	P	Direct
Common Stock	Acquisiton	2019-10-11	65	$5.71	165,132	No	4	P	Direct
Common Stock	Acquisiton	2019-10-14	65	$5.67	165,197	No	4	P	Direct
Common Stock	Acquisiton	2019-10-15	65	$5.63	165,262	No	4	P	Direct
Common Stock	Acquisiton	2019-10-16	65	$5.56	165,327	No	4	P	Direct
Common Stock	Acquisiton	2019-10-17	65	$5.52	165,392	No	4	P	Direct
Common Stock	Acquisiton	2019-10-18	65	$5.45	165,457	No	4	P	Direct
Common Stock	Acquisiton	2019-10-19	38	$5.51	165,495	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.